These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15346947)

  • 1. [Immunostimulating activity of polycomponent vaccine "Immunovac-VP-4" and grippol after their combined administration].
    Kurbatova EA; Semenov BF; Egorova NB; Efremova VN; Gruber IM; Semenova IB; Kushchenko OM
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (3):34-9. PubMed ID: 15346947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dynamics of autoantibodies in elderly persons in the process of vaccination with Grippol and multicomponent vaccine VP-4].
    Egorova NB; Semenov BF; Kurbatova EA; Iastrebova NE; Poddubikov AV; Efremova VN; Semenova IB
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (5):29-35. PubMed ID: 12524997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The evaluation of the reactogenicity, harmlessness and prophylactic efficacy of Grippol trivalent polymer-subunit influenza vaccine administered to schoolchildren].
    El'shina GA; Gorbunov MA; Bektimirov TA; Lonskaia NI; Pavlova LI; Nikul'shin AA; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (2):50-4. PubMed ID: 10808574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prophylactic efficacy of the trivalent polymer-subunit influenza vaccine Grippol (3)].
    El'shina GA; Gorbunov MA; Shervarli VI; Lonskaia NI; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG; Pavlova LI; Malinovskiĭ AA
    Voen Med Zh; 1997 Feb; 318(2):47-9. PubMed ID: 9148581
    [No Abstract]   [Full Text] [Related]  

  • 5. [The antigenic-immunogenic activity of the trivalent polymer-subunit influenza vaccine Grippol in a controlled epidemiological trial (2)].
    El'shina GA; Masalin IuM; Shervarli VI; Gorbunov MA; Lonskaia NI; Agafonova LV; Khaitov RM; Nekrasov AV; Ivanova AS
    Voen Med Zh; 1996 Nov; 317(11):53-5. PubMed ID: 9036633
    [No Abstract]   [Full Text] [Related]  

  • 6. [Protective efficacy of combined administration of the multicomponent vaccine and the immunomodulator myelopid in experimental infections in mice].
    Stepanenko RN; Egorova NB; Kurbatova EA; Efremova VN; Kuz'mina LA; Skoptsova SV; Novikova EM; Kondarshova MM; Gruber IM
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (5):48-52. PubMed ID: 11220965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protective effect of the aerosol immunization of mice with the polycomponent vaccine Immunovac VP-4 after the challenge of the animals with Klebsiella pneumoniae virulent strain].
    Solov'ev KG; Kurbatova EA; Egorova NB; Uspenskaia SN; Tret'iakova AV; Varfolomeev AN; Gruber IM; Efremova VN; Akhmatova NK; Diadizhshev NR; Akhmatova IB; Diadishchev NR; Semenova IB; Cherkasova LS; Semenov BF; Borovik RV
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (1):20-5. PubMed ID: 16532635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The trivalent polymer-subunit influenza vaccine Grippol studied in a controlled epidemiological trial (1)].
    El'shina GA; Masalin IuM; Shervali VI; Gorbunov MA; Lonskaia NI; Agafonova LV; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG
    Voen Med Zh; 1996 Aug; 317(8):57-60. PubMed ID: 9036650
    [No Abstract]   [Full Text] [Related]  

  • 9. [Protective activity of Immunovac-VP-4 vaccine against avian influenza virus H5N2 administered by different methods].
    Egorova NB; Kurbatova EA; Akhmatova NK; Semenova IB
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (1):49-53. PubMed ID: 21446167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of methods of application of bacterial ligands on activation of lymphoid organs' effectors in mice].
    Akhmatova NK; Chertov IV; Akhmatov EA; Kurbatova EA; Egorova NB; Semenova IB
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (3):56-61. PubMed ID: 20737684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The protective activity of a multicomponent vaccine made from the antigens of opportunistic microorganisms when administered orally].
    Egorova NB; Mansurova NL; Kuz'mina LA; Kaverina KG
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):48-51. PubMed ID: 8067073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative evaluation of the reactogenicity and immunogenicity of inactivated influenza vaccines in the elderly].
    Burtseva EI; Slepushkin AN; Vlasova LN; Oskerko TA; Fedorova GI; Stepnova AI; Beregovskiĭ NA
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (5):40-5. PubMed ID: 11220963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunovac-VP-4 for prevention of acute respiratory diseases in children's communities].
    Egorova NB; Kurbatova EA; Gruber IM; Semenova IB
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (6):35-40. PubMed ID: 21381375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The evaluation of the epidemiological efficacy of 3-component inactivated influenza vaccines using an intranasal application method].
    Marinich IG; Iaroshevskaia IIu; Konareva AL; Lonskaia NI; Shadrin AS; Salmin LV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):76-8. PubMed ID: 8079581
    [No Abstract]   [Full Text] [Related]  

  • 15. [Epidemiological and economic effectiveness of immunization of adult and children against influenza and acute respiratory viral infections with the vaccine Grippol].
    Khaitov RM; Nekrasov AV; Puchkova NG; Ivanova AS
    Zh Mikrobiol Epidemiol Immunobiol; 2003; (3):83-6. PubMed ID: 12886641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An immunogenicity and reactogenicity study of a purified, inactivated trivalent influenza vaccine for parenteral administration prepared for the 1996-1997 season].
    Lupulescu E; Ioniţă E; Botez D; Matepciuc M; Tabra ME; Tecu C; Alexandrescu V; Munţiu A
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(1-2):110-2. PubMed ID: 9235136
    [No Abstract]   [Full Text] [Related]  

  • 17. Modern vaccines. Pneumococcus and influenza.
    Shann F
    Lancet; 1990 Apr; 335(8694):898-901. PubMed ID: 1969994
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of therapeutic polycomponent vaccine "Immunovac VP-4" for the treatment of chronic bacterial prostatitis].
    Bondarenko VM; Vershinin AE; Kucherskiĭ VM; Mitkov VG; Klimova NE; Kurbatova EA; Egorova NB
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (3):39-43. PubMed ID: 15346948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Concept of inducing of rapid immunological protection against pathogens].
    Semenov BF; Zverev VV
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (4):93-100. PubMed ID: 17882839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects.
    Squarcione S; Sgricia S; Biasio LR; Perinetti E
    Vaccine; 2003 Mar; 21(11-12):1268-74. PubMed ID: 12559808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.